TOIThe Oncology Institute Inc. Common Stock

6.200USD+0.16%Mkt Cap: 512.91M $P/E:

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The compa…

HeadlineSourceTime
Older
Oncology Institute Q2 Earnings Call Highlights

Oncology Institute (NASDAQ:TOI) reported second-quarter revenue growth, positive adjusted EBITDA and an expanded pipeline of value-based oncology contracts as the company announced it has rebranded as Starling Oncology. Chief Executive Officer Dan Virnich said the new name reflects the company’s ev

MarketBeat
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates

STARLING ONCOLO (STLN) delivered earnings and revenue surprises of -14.29% and +5.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10?

The Oncology Institute Inc. (NASDAQ:TOI) is one of the best future stocks to buy under $10. On July 7, the Oncology Institute announced the completion of a strategic refinancing deal with OrbiMed, which allowed the company to repay its $86 million senior secured convertible note previously held by Deerfield Partners. This transaction was executed using […]

IInsider Monkey
Zacks
IInsider Monkey
Zacks
Zacks